Literature DB >> 9248715

Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues.

B Williams1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9248715     DOI： 10.1007/s001250051423

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II.

Authors:  I Idris; N Tyreman; S Gray; R Donnelly
Journal:  Diabetologia       Date:  2002-02       Impact factor: 10.122

Review 2.  Cerebrovascular complications of diabetes: focus on cognitive dysfunction.

Authors:  Trevor Hardigan; Rebecca Ward; Adviye Ergul
Journal:  Clin Sci (Lond)       Date:  2016-10-01       Impact factor: 6.124

Review 3.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

Review 4.  Mechanisms of endothelial dysfunction in the metabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 5.  Vascular endothelial growth factors and vascular permeability.

Authors:  David O Bates
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

6.  Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemia.

Authors:  Yoka H Kusumanto; Coby Meijer; Wendy Dam; Nanno H Mulder; Geke A P Hospers
Journal:  Drug Target Insights       Date:  2007-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.